Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease of unknown etiology,
involving complex interactions between the gut microbiome and host immune response. The …

Introduction Crohn's disease (CD) is a complex disease, and assessing activity is
challenging due to pathobiologic process eg ECM remodeling, mucosal damage, and …

Ulcerative colitis (UC) is one form of inflammatory bowel disease (IBD), characterized by
chronic relapsing intestinal inflammation. As increasing morbidity of UC and deficiency of …

Background The indolent course of treatment-naive patients with inflammatory bowel
disease (IBD) is confirmed predictable based on clinical characteristics. Current evidences …

Crohn's disease (CD) is an inflammatory bowel disease (IBD) with complex clinical
manifestations such as chronic diarrhea, weight loss and hematochezia. Despite the …

The gut microbiome has been recognised as a key component in the pathogenesis of
inflammatory bowel diseases (IBD), and the wide range of metabolites produced by gut …

Background & aims Intestinal fibrosis is a common and severe complication of inflammatory
bowel disease without clear pathogenesis. Abnormal expression of host genes and …

Inflammatory bowel disease (IBD) is an immune-mediated disease characterized by chronic
mucosal inflammation of the digestive tract. The IBD diagnosis is currently based on the …

Ulcerative colitis (UC) is a part of the cluster of conditions–known as inflammatory bowel
disease. It is caused by a plethora of factors that on a long-term basis result in inflammation …

Lesniowski-Crohn's disease (CD) is a type of chronic inflammatory bowel disease (IBD) of
uncertain etiology. Initially, pharmacological management is undertaken; however, surgical …